(Total Views: 436)
Posted On: 03/10/2021 2:29:00 PM
Post# of 148981
write to Janet Woodcock, FDA Director
Say anything, just ask to give EUA to Cytodyn for Leronlimab
To save lives of "Critical Covid-19 Patients" per Phase III s/c Data
Janet.woodcock@fda.hhs.gov
Hey, 24% reduction in s/c deaths vs SOC, saving lives
31.8% reduction is critical deaths for folks under 66, saving lives
Nader did clearly say that Cytodyn was applying for "Conditional Approval" (authorization, an EUA) while gathering data in the 140 patient Critical Trial.
I suppose he meant after enrollment was completed at 140? You think?
Boldly superior to criteria needed for an EUA.
What's the deal hear Janet, BP got you by the throat?
Yeah, many of us are angry, not only huge losses,
But many unnecessary death, people dying that need not die and
huge deserved gains not gained.
Say anything, just ask to give EUA to Cytodyn for Leronlimab
To save lives of "Critical Covid-19 Patients" per Phase III s/c Data
Janet.woodcock@fda.hhs.gov
Hey, 24% reduction in s/c deaths vs SOC, saving lives
31.8% reduction is critical deaths for folks under 66, saving lives
Nader did clearly say that Cytodyn was applying for "Conditional Approval" (authorization, an EUA) while gathering data in the 140 patient Critical Trial.
I suppose he meant after enrollment was completed at 140? You think?
Boldly superior to criteria needed for an EUA.
What's the deal hear Janet, BP got you by the throat?
Yeah, many of us are angry, not only huge losses,
But many unnecessary death, people dying that need not die and
huge deserved gains not gained.
(2)
(0)Scroll down for more posts ▼
